AbbVie, Inc. (ABBV)
219.68
-5.69
(-2.52%)
USD |
NYSE |
Mar 13, 16:00
219.60
-0.08
(-0.04%)
After-Hours: 20:00
AbbVie EPS Diluted (Quarterly) : 1.018 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Biogen, Inc. | -0.3333 |
| Gilead Sciences, Inc. | 1.742 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.805B |
| Revenue (Quarterly) | 16.62B |
| Total Expenses (Quarterly) | 14.81B |
| Enterprise Value | 451.40B |
| Gross Profit Margin (Quarterly) | 72.63% |
| Profit Margin (Quarterly) | 10.86% |
| Earnings Yield | 1.07% |
| Operating Earnings Yield | 5.15% |
| Normalized Earnings Yield | 3.198 |